BMRA - BIOMERICA INC
2.18
0.020 0.917%
Share volume: 10,376
Last Updated: 04-22-2026
Pharmaceutical Products/In Vitro, In Vivo Diagnostic Substances:
-0.03%
PREVIOUS CLOSE
CHG
CHG%
$2.16
0.02
0.01%
View ratios
| Fiscal Date | 02-29-2024 | 05-31-2024 | 08-31-2024 | 11-30-2024 | 02-28-2025 | 08-31-2025 | 11-30-2025 | 02-28-2026 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q1 2026 | Q2 2026 | Q3 2026 | |
| Report Date | 04-12-2024 | 01-14-2025 | 10-15-2024 | 01-14-2025 | 04-14-2025 | 10-14-2025 | 01-14-2026 | 04-13-2026 | |
| Cash flow financing | 0.000 | -81.000 K | 0.000 | 380.000 K | 1.736 M | 920.000 K | 482.000 K | 61.000 K | |
| Other financing cash flows | 0.000 | 0.000 | 0.000 | 0.000 | 77.000 K | 0.000 | 0.000 | 0.000 | |
| Cash flow | 0.000 | -1.149 M | -1.344 M | -444.000 K | 687.000 K | 652.000 K | 0.000 | -1.208 M | |
| Net income | -1.918 M | -1.421 M | -1.316 M | -950.000 K | -1.163 M | 2.000 K | -1.320 M | -1.312 M | |
| Depreciation | 20.000 K | 22.000 K | 21.000 K | 22.000 K | 21.000 K | 20.000 K | 20.000 K | 20.000 K | |
| Changes in inventories | 0.000 | 0.000 | -429.000 K | 0.000 | 0.000 | -10.000 K | 0.000 | 0.000 | |
| Changes in receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Cashflow | -16.000 K | -24.000 K | 0.000 | -33.000 K | -4.000 K | 0.000 | 0.000 | -19.000 K | |
| Net Borrowings | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Activity Other | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Dividends Paid | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Exchange Rate Effect | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Capital Expenditures | 0.000 | 24.000 K | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cash Change | -1.815 M | -1.149 M | -1.350 M | -448.000 K | 686.000 K | 654.000 K | -510.000 K | -1.207 M |